Highlights ValiRx plc

Equities

Delayed London S.E. Other stock markets 03:30:56 2024-05-21 EDT			5-day change	1st Jan Change
3.55 ^GBX	-11.25%		+16.39%	-39.83%

05-20	London gets boost thanks to rate cut hopes	AN
05-20	ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant	AN

London gets boost thanks to rate cut hopes	05-20	AN
ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant	05-20	AN
EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target	05-16	AN
Vertu Motors ups dividend as hails record revenue	05-15	AN
AIM WINNERS & LOSERS: Itim up on Majestic Wine contract renewal	05-15	AN
ValiRx plc Reports Earnings Results for the Full Year Ended December 31, 2023	05-15	CI
Valirx plc Reiterates Earnings Guidance for the Year 2024	04-24	CI
ValiRx inks evaluation deal with Imperial College London for research	03-21	AN
ValiRx plc Announces Signature of an Evaluation Agreement with Imperial College London	03-21	CI
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat	03-19	AN
EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout	02-29	AN
ValiRx signs research sharing deal with Dundee University	02-12	AN
Valirx Signs Research, Evaluation Agreements with University of Dundee	02-12	MT
ValiRx plc Announces Agreement with Dundee Uni and Project Initiation	02-12	CI
ValiRx receives shareholder request for board change	02-09	AN
Good Energy says ZapMap expands into mainland Europe	12-13	AN
ValiRx Signs Licensing Option Deal with Ambrose Healthcare	12-05	MT
ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose	12-05	AN
ValiRx signs deal to evaluate StingRay Bio drug candidates	11-10	AN
ValiRX, StingRay Bio Sign Evaluation Agreement for Oncology Drug Candidates	11-10	MT

No results for this search